SCHEMBL2595207

SCHEMBL2595207

O=C1C(=CO)C2(CCN(C(=O)O)CC2)Oc2cccnc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.41
ACACB O00763 2/20 0.39
HSD11B1 P28845 5/20 0.36
CACNA1C Q13936 1/20 0.33
NPC1 O15118 1/20 0.33
CYP3A4 P08684 3/20 0.32
CYP2C9 P11712 3/20 0.32
CYP2C8 P10632 1/20 0.32
CYP2C19 P33261 1/20 0.32
CYP46A1 Q9Y6A2 1/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
NPY5R Q15761 1/20 0.32
USP2 O75604 1/20 0.32
CYP1A2 P05177 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NSD2 O96028 3/20 0.32
HDAC3 O15379 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12180668 0.84 POLB (0.43) ACACB
SCHEMBL2592595 0.81 HDAC3 (0.39) EPHX2HSD11B1CYP2C9NPY5RHDAC3
SCHEMBL2592588 0.81 HDAC3 (0.39) EPHX2HSD11B1CYP2C9NPY5RHDAC3
SCHEMBL14919198 0.75 EPHX2 (0.64) EPHX2ACACBCACNA1CCYP2C9HDAC3
SCHEMBL23928898 0.69 EPHX2 (0.54) EPHX2ACACBCACNA1CNPC1HDAC3
SCHEMBL22980435 0.67 POLB (0.47) EPHX2ACACB
SCHEMBL21383845 0.67 HDAC3 (0.48) EPHX2HSD11B1CYP2C9NPY5RHDAC3
SCHEMBL12180373 0.67 KMT2A (0.47) NPC1CYP2C19ALDH1A1SMN1; SMN2HSD17B10
SCHEMBL12180395 0.66 PDK4 (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL2594758 0.66 PDK4 (0.42) HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2595989-A1 HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS Vertex Pharmaceuticals Incorporated (US) 2013-05-29 EP disclosed
WO-2013067248-A1 BENZOXAZINES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-05-10 WO disclosed
WO-2011140425-A1 HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-11-10 WO disclosed